Heart failure (HF) is a worldwide public health problem. Hospitalization for HF accounts for 6.5 million hospital days spent annually in the United States with nearly 50% of patients requiring readmission in the 6 months following initial hospitalization [1] [2] . In addition to its high prevalence, hospitalization for decompensated HF is associated with extraordinarily high rates of morbidity and mortality. Aranda et al. analyzed Medicare data and found that in the 6 to 9 months following initial hospitalization for HF, 60% of the patients had readmission from any cause with HF accounting for 28% of readmissions [3] . In a recent meta-analysis, Lan et al. reported an all-cause readmission rate of 53% and 36% for HF [4] . The high prevalence and morbidity associated with decompensated HF combine to create a substantial economic burden on the healthcare system. The total yearly cost of HF reported in the United States in 2009 was estimated to be $37.2 billion of which $20 billion were related to hospitalization [5] . This social and economic burden of HF hospitalization is certainly greater in Africa where the disease affects men and women in their most productive years of life, at a median age of 55 years, and where many countries lack universal health care [6] . There is also a scarcity of updated data, especially related to heart failure readmissions. This study aimed to determine the prevalence of re-hospitalization for HF and to describe the clinical and paraclinical presentation of patients in the Yaoundé General Hospital.

A total of 160 patients were included in the study. Forty-nine (30.6%) were readmitted for HF. The sex ratio was 1.6 with a mean age of 71.0 ± 13.9 years, and almost two-thirds had > 70 years. Most of them (81.6) lived in urban areas. The most common etiologies (Figure 1) of HF in re-hospitalized patients were hypertensive heart disease (36.7%) followed by dilated cardiomyopathy (22.5%) and atrial fibrillation (16.3%). Associated comorbidities (Figure 2) were mainly hypertension (51.1%), alcohol consumption (51.0%), and atrial fibrillation (34.7%).

Table 1 shows the clinical presentation of re-hospitalized patients. More than two third had New York Heart Association class IV disease. Laboratory studies revealed anemia in 77.6% of re-hospitalized patients, altered glomerular filtration rate < 60 ml/kg/m² body surface area in 32.7% and hyponatremia in 44.9%. Twenty-four (49.0%) patients had pleural effusion on chest X-ray and atrial fibrillation was the most common (46.9%) anomaly on electrocardiography. Evaluation of left ventricular ejection fraction on cardiac ultrasound showed that more than two third (71.4%) of the patients re-hospitalized had reduced ejection fraction (HFrEF). Table 2 shows the overall results from the paraclinical workup. The patients were treated using diuretics (93.4%), angiotensin-converting enzyme inhibitors (ACEI)/angiotensin II receptor blockers (ARB) (81.6%), beta-blockers (77.6%) and digoxin (48.9%).

We found in this study a prevalence of re-hospitalization for decompensated HF of 30.6%. This prevalence was determined out of any timeframe since all readmissions during our study period were considered. Thus, it may be overestimated compared to other studies that often report the prevalence of re-hospitalizations within a certain timeframe. Some authors have reported a high readmission rate for HF in Africa. Okello et al. in Uganda reported a prevalence of readmissions of 31.4% within a 12-month study period, while Akpa and Iheji found 35.6% after 6 months in Nigeria [7] [8] . This prevalence in sub-Saharan Africa is higher than that reported in the United States of America where Aranda, J.M. et al. [3] found 16.8% of readmission for HF in the 6 to 9 months following initial HF hospitalization. One reason why we had a higher rate of readmission may be because not all our patients were receiving the evidence-based medications recommended for

Bpm: beat per minute, Cpm: beat per minute, SD: standard deviation, NYHA: New York Heart Association.

SD: standard deviation, WBC: white blood cells, GFR: glomerular filtration rate, HFpEF: heart failure with preserved ejection fraction, HFmrEF: heart failure with mildly reduced ejection fraction, HFrEF: heart failure with reduced ejection fraction.

the reduction of hospitalization and death, even though most of them had HFrEF. In our study, we had 81.6% treated with ACEI/ARB, 77.6% with beta-blockers and none of them were treated with mineralocorticoid receptor antagonists or ivabradine. Similarly in the study of Okello, S. et al., [7] only 32.9% and 27.0% of the patients were treated respectively with ACEI/ARB and beta-blockers. Most of our re-hospitalized patients were male, had old age, class IV NYHA disease, HFrEF, and anemia. Whether these characteristics are associated with readmissions needs to be determined in further studies.

There was a high rate of re-hospitalization for HF in the cardiology unit of the Yaoundé General Hospital during our study period. Re-hospitalized patients had mostly old age, class IV NYHA disease, HFrEF, and anemia. Further studies are needed to assess the determiners of re-hospitalization in these patients.

Amalia Owona, Ning Lom Bryan-Bill, Ahmadou Musa Jingiand Alain Patrick Menanga designed the study. Ning Lom Bryan-Bill collected the data. Ning Lom Bryan-Bill and Dieudonne Danwe performed the statistical analysis. Amalia Owona and Dieudonne Danwe drafted the manuscript. Alain Patrick Menanga did the overall supervision.

The authors declare no conflicts of interest regarding the publication of this paper.

Owona, A., Bryan-Bill, N.L., Jingi, A.M., Danwe, D. and Menanga, A.P. (2023) Prevalence of Re-Hospitalization for Heart Failure in a Cameroonian Tertiary Hospital: A Cross-Sectional Study. World Journal of Cardiovascular Diseases, 13, 333-340. https://doi.org/10.4236/wjcd.2023.136031